ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TRX Tissue Regenix Group Plc

61.50
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00BNTXR104 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 61.50 61.00 62.00 61.50 61.50 61.50 58,537 08:00:21
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 29.49M -302k -0.0043 -143.02 43.4M
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 61.50p. Over the last year, Tissue Regenix shares have traded in a share price range of 49.00p to 71.50p.

Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £43.40 million. Tissue Regenix has a price to earnings ratio (PE ratio) of -143.02.

Tissue Regenix Share Discussion Threads

Showing 13701 to 13724 of 14750 messages
Chat Pages: Latest  554  553  552  551  550  549  548  547  546  545  544  543  Older
DateSubjectAuthorDiscuss
01/9/2021
08:32
You can forget the move down!
pennstreet
01/9/2021
08:28
Post .72p chart suggesting move back down to .65/.67 which I presume will be on results. A break/close above .76 is positive.
red army
01/9/2021
08:22
Ahhhh! Been watching these for a couple of weeks, hoping I could get them cheaper. Had to stump up .7238p for 2m. That'll teach me to try and be a smart ar*se.
gsg
01/9/2021
07:58
Great news!!
pennstreet
01/9/2021
07:15
Launch of DermaPure(R) Meshed and VNEW(TM)

Both line extensions to the Biosurgery division, utilising the dCELL (R) Technology platform

Tissue Regenix (AIM: TRX), the regenerative medical technology company, announces the launch of DermaPure(R) Meshed and VNEW(TM) , both line extensions to the Company's BioSurgery division, utilising Tissue Regenix's patented decellularisation ('dCELL(R)') Technology.

DermaPure(R) Meshed provides surgeons with a customised new DermaPure(R) option that eliminates time consuming manual meshing in the operating room, allows for wound fluid egress, thereby optimising patient outcomes and is meshed to provide an expansion area of 1.8X, allowing for greater surface area coverage. The product is targeted for use by general, plastic and trauma surgeons who treat patients with conditions that result in loss of integumental tissue (skin), requiring replacement, repair, or reconstruction. DermaPure(R) Meshed is a niche addition to our current portfolio for our customer base.

VNEW(TM) is available exclusively through the Company's distribution partner ARMS Medical ('ARMS'), which it entered into a multi-year exclusive distribution agreement (the "Agreement") with in 2018. The Agreement granted ARMS exclusive rights to distribute DermaPure(R) to hospitals and surgeons throughout the US for use in urology and gynecology procedures, focused on women's pelvic health issues. VNEW(TM) , the pre-shaped, pre-cut acellular dermal allograft, is designed to facilitate pelvic organ prolapse surgical procedures intended to repair, reconstruct, and reinforce damaged or weakened tissue. Approximately 300,000 women annually undergo surgery for pelvic organ prolapse(1) . Tissue Regenix has already fulfilled its initial stocking order for VNEW(TM) .

Both products utilise the Company's patented dCELL(R) Technology, which unlike alternative processes, removes 99% of DNA and other cellular debris with virtually no structural disruption, differentiating itself from other technologies, thus providing optimal repair, replacement, and / or reconstruction of the damaged extracellular matrix, as well as providing structural support, allowing the patient's living, native cells to populate and integrate ultimately achieving the surgeons' goal of soft tissue healing.

Daniel Lee, CEO of Tissue Regenix, commented: "We are pleased to launch two new products using our patented dCELL(R) Technology, extending our product lines and helping drive market penetration with our diversified portfolio."

david gruen
31/8/2021
12:17
Sell at your peril !! Good news is just round the corner ;0)
pennstreet
31/8/2021
06:45
Tnt99

I have 'waders' and they are overflowing. Haven't bought any more for a little while due to being "overweight" here already.

Would not normally buy so much in one company (TRX), but I see this as an opportunity to try and recover a "megga" amount of dosh lost when I was invited to take part in a placing thirteen years ago after a "face to face" meeting with CEO / MD of a company which then delisted from the market three months later after the placing and have never traded again.

Fingers Crossed ✌ and hope Lightening doesn't strike twice !!

channel pirate
29/8/2021
22:25
My boots are already full on this one
tnt99
28/8/2021
10:34
I see a Higher High on my charts. When is the interim announcement due. Is it next week??
rocketblast
27/8/2021
15:53
3M buy!

Feeling nervously confident following my much smaller purchase

contact2fsnetcouk
27/8/2021
15:49
Just added a few before the interim announcement.

GLA

contact2fsnetcouk
27/8/2021
08:22
A rising wedge pattern can be very bullish but needs to break/close above .75p
red army
27/8/2021
08:08
News after bank holiday weekend?
pennstreet
26/8/2021
16:06
Volume increasing nicely on the upswings. I'm holding out for a better payday than 1.3p though.
alancapone
26/8/2021
16:03
Come on you little beauty
jpuff
26/8/2021
14:28
Must be RNS being released on great news. Agree it can double and 1.3p is easy reach.
rocketblast
26/8/2021
10:36
It seems stockopedia think this share is 93% under true value hope they have got this right means shares could double if the news is goodDirectors buys give me some confidence wish they had been a bit larger though
tnt99
19/8/2021
07:57
Surely the time to add is before the update? Fill your boots while you can ;0)
pennstreet
17/8/2021
11:42
Should see a steady rise here in anticipation of the interims hope they don't disappoint, the directors buys would suggest it will be good news Everything crossed
tnt99
14/8/2021
18:41
I think their runway of money will be used up in around 18 months if trading hasn't improved the question is what will they do they can hardlyDo another fund raise at these lowly prices without diluting the current holders vastly Hope this question will be answered in the results due soon and trading is up by at least 50 per cent then the share price should rise by how much is anybodies guess but it would make them near break even
tnt99
14/8/2021
07:32
Good spot. Hence zero effect on sp
pennstreet
14/8/2021
06:43
ingroid what I am saying is that the gain of the three large BUYS totalling 5714300 shares just after mid afternoon are wiped out by the SELL of the same one total after the market has closed !!
channel pirate
13/8/2021
23:05
5,714,300 at .70 is only around £40,000
ingroid
13/8/2021
22:06
PennStreet take a closer look :-

This afternoons large trades:

15:46 3714300 0.704p
15:48 1000000 0.70p
15:49 1000000 0.70p

TOTAL 5714300 BUYS


17:05 5714300 0.69p SOLD

channel pirate
Chat Pages: Latest  554  553  552  551  550  549  548  547  546  545  544  543  Older

Your Recent History

Delayed Upgrade Clock